DV
Dividend Vision

ACON — Aclarion Inc

Aclarion Inc (ACON)

Its deepest 1-year drawdown was 79.2%.

Aclarion Inc is a healthcare technology company that develops magnetic resonance spectroscopy-based diagnostic tools for analyzing spinal disc degeneration, including its NOCISCAN system for non-invasive assessment of intervertebral discs and supporting software products for data processing and imaging transfer. The company does not currently distribute dividends. Aclarion appeals primarily to investors focused on healthcare innovation and biotechnology exposure rather than income generation.

ACON key facts

Asset type
Stock
Asset class
Equity
Inception date
04/22/2022
Last close
$2.46
Market cap
$6,352,605
Average volume
35695.0
Beta
1.206
Payout ratio
0.0
Forward P/E
0.0
EPS
$-5.63